After Heparin: - The Pew Charitable Trusts

REFERENCES
219
U.S. Food and Drug Administration. The Enforcement Story, Fiscal Year 2001. Chapter 6: Office of Criminal Investigation.
http://www.fda.gov/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/ucm106657.htm Accessed
August 22, 2010.
220
Ibid.
221
Ibid.
222
Ibid.
223
U.S. Food and Drug Administration. The Enforcement Story, Fiscal Year 2005. Chapter 6: Office of Criminal Investigations.
March 2006. http://www.fda.gov/downloads/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/
UCM091079.pdf. Accessed August 22, 2010.
224
U.S. Food and Drug Administration. The Enforcement Story, Fiscal Year 2001. Chapter 6: Office of Criminal Investigation.
http://www.fda.gov/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/ucm106657.htm Accessed
August 22, 2010.
225
Lewis, Carol. FDA Investigators’ Reports—January–February 2002. FDA Consumer Magazine. January 4, 2002.
226
Ibid.
227
21 USC §331(j).
228
Rentz, E.D., L. Lewis, et al. Outbreak of Acute Renal Failure in Panama in 2006: a Case-Control Study. Bull World Health
Organ 2008; 86:749–756.
229
Ibid.
230
Schep, L.J., R.J. Slaughter, et al. Diethylene Glycol Poisoning. Clinical Toxicology. 2009. Vol. 47 No. 6.
231
Rentz, E.D., L. Lewis, et al. Outbreak of Acute Renal Failure in Panama in 2006: a Case-Control Study. Bull World Health
Organ, 2008, 86:749–756.
232
Rivera-Martinez, Edwin. Chief, Manufacturing Assessment and Preapproval Compliance Branch, Division of Manufacturing
& Product Quality, Office of Compliance, Center for Drug Evaluation & Research, U.S. Food and Drug Administration.
“Ensuring the Integrity of the Pharmaceutical Ingredient Supply Chain.” Presentation at the 2008 PDA/FDA Pharmaceutical
Ingredient Supply Chain Conference, San Diego, Calif. December 1, 2008.
233
Schier, J.G., C.S. Rubin, et al. Medication-associated Diethylene Glycol Mass Poisoning: A Review and Discussion on the
Origin of Contamination. Journal of Public Health Policy. 2009. Vol. 30, No. 2.
234
Rivera-Martinez, Edwin. Chief, Manufacturing Assessment and Preapproval Compliance Branch, Division of Manufacturing
& Product Quality, Office of Compliance, Center for Drug Evaluation & Research, U.S. Food and Drug Administration.
“Ensuring the Integrity of the Pharmaceutical Ingredient Supply Chain.” Presentation at the 2008 PDA/FDA Pharmaceutical
Ingredient Supply Chain Conference, San Diego, Calif. December 1, 2008.
235
Schier, J.G., C.S. Rubin, et al. Medication-associated Diethylene Glycol Mass Poisoning: A Review and Discussion on the
Origin of Contamination. Journal of Public Health Policy. 2009. Vol. 30, No. 2.
236
Rentz, E.D., L. Lewis, et al. Outbreak of Acute Renal Failure in Panama in 2006: a Case-Control Study. Bull World Health
Organ, 2008, 86:749–756.
237
Ballentine, Carol. Taste of Raspberries, Taste of Death. The 1937 Elixir Sulfanilamide Incident. FDA Consumer, June 1981.
http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SulfanilamideDisaster/default.htm Accessed
October 15, 2010.
238
Schep, L.J., R.J. Slaughter, et al. Diethylene Glycol Poisoning. Clinical Toxicology. 2009. Vol. 47 No. 6.
239
Ibid.
240
Bogdanich, Walt, and Jake Hooker. From China to Panama, a Trail of Poisoned Medicine. New York Times. May 6, 2007.
http://www.nytimes.com/2007/05/06/world/americas/06poison.html?pagewanted=1. Accessed February 1, 2010.
241
O’Brien K.L., J.D. Selanikio, et al. Epidemic of Pediatric Deaths from Acute Renal Failure Caused by Diethylene Glycol
Poisoning. Acute Renal Failure Investigation Team. JAMA 1998; 279:1175–1180.
242
Junod, Suzanne White. Diethylene Glycol Deaths in Haiti. Public Health Reports, January–February 2000, Vol. 115, No. 1.
243
Singh, J., A.K. Dutta, et al. Diethylene Glycol Poisoning in Gurgaon, India, 1998. Bull World Health Organ, 2001, 79:88–95.
After Heparin: PRotecting Consumers from the Risks of Substandard and Counterfeit Drugs 89